NASDAQ:OFIX Orthofix Medical Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $23.55 -0.20 (-0.84%) (As of 06/29/2022 05:49 PM ET) Add Compare Share Today's Range$23.36▼$24.0550-Day Range$23.55▼$34.8552-Week Range$23.36▼$43.30Volume85,898 shsAverage Volume102,593 shsMarket Capitalization$468.93 millionP/E RatioN/ADividend YieldN/APrice Target$45.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive OFIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address OFIX Stock Forecast (MarketRank)Overall MarketRank™2.11 out of 5 starsMedical Sector483rd out of 1,432 stocksSurgical & Medical Instruments Industry57th out of 137 stocksAnalyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 - 3.5 Analyst's Opinion Consensus RatingOrthofix Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $45.00, Orthofix Medical has a forecasted upside of 91.1% from its current price of $23.55.Amount of Analyst CoverageOrthofix Medical has received no research coverage in the past 90 days. Previous Next 4.1 Community Rank Outperform VotesOrthofix Medical has received 386 “outperform” votes. (Add your “outperform” vote.)Underperform VotesOrthofix Medical has received 235 “underperform” votes. (Add your “underperform” vote.)Community SentimentOrthofix Medical has received 62.16% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote “Outperform” if you believe OFIX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldOrthofix Medical does not currently pay a dividend.Dividend GrowthOrthofix Medical does not have a long track record of dividend growth. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Orthofix Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.50% of the stock of Orthofix Medical is held by insiders.Percentage Held by Institutions97.93% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Orthofix Medical are expected to grow by 10.17% in the coming year, from $0.59 to $0.65 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Orthofix Medical is -12.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Orthofix Medical is -12.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrthofix Medical has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Orthofix Medical (NASDAQ:OFIX)Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.Read More OFIX Stock News HeadlinesJune 19, 2022 | finance.yahoo.comIs Now An Opportune Moment To Examine Orthofix Medical Inc. (NASDAQ:OFIX)?June 16, 2022 | marketwatch.comSpine Biologics Market Share, Size 2022 | Business Revenue, Future Growth, Trends, Top Key Players, Business Opportunities | Forecast to 2028June 14, 2022 | marketwatch.comGlobal Bracing and Support (B&S) Market Advancement and Future Scope Till 2027June 12, 2022 | americanbankingnews.comOrthofix Medical (NASDAQ:OFIX) Hits New 1-Year Low at $26.05June 6, 2022 | nz.finance.yahoo.comWorldwide Trauma Implants Industry to 2031 - Featuring Conformis, Orthofix Medical and Acumed Among OthersJune 1, 2022 | msn.comLooking Into Orthofix Medical's Return On Invested CapitalMay 31, 2022 | finance.yahoo.comOrthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five YearsMay 31, 2022 | finance.yahoo.comA number of insiders bought Orthofix Medical Inc. (NASDAQ:OFIX) stock last year, which is great news for shareholdersMay 18, 2022 | tmcnet.comCatalyst OrthoScience Announces Todd Wilson, PhD as Vice President of Medical Education and TrainingMay 6, 2022 | finance.yahoo.comOrthofix (OFIX) Reports Q1 Loss, Tops Revenue EstimatesMay 6, 2022 | finance.yahoo.comOrthofix Reports First Quarter 2022 ResultsMay 4, 2022 | marketwatch.comOrthofix Receives FDA Premarket Approval for Bone-Healing DeviceMay 4, 2022 | finance.yahoo.comFDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy SolutionsSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:OFIX CUSIPN6748L10 CIK884624 Webwww.orthofix.com Phone(214) 937-2000Fax599 9 461 6978Employees1,087Year Founded1980Company Calendar Last Earnings5/06/2022Today6/29/2022Next Earnings (Estimated)8/05/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$45.00 High Stock Price Forecast$45.00 Low Stock Price Forecast$45.00 Forecasted Upside/Downside+91.1%Consensus RatingBuy Rating Score (0-4)3 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.860010) Trailing P/E RatioN/A Forward P/E Ratio39.92 P/E GrowthN/ANet Income$-38.38 million Net Margins-7.96% Pretax Margin-2.55% Return on Equity3.34% Return on Assets2.41% Debt Debt-to-Equity Ratio0.06 Current Ratio2.89 Quick Ratio1.88 Sales & Book Value Annual Sales$464.48 million Price / Sales1.01 Cash Flow$3.01 per share Price / Cash Flow7.83 Book Value$16.99 per share Price / Book1.39Miscellaneous Outstanding Shares19,912,000Free Float19,215,000Market Cap$468.93 million OptionableOptionable Beta0.97 Social Links Orthofix Medical Frequently Asked Questions Should I buy or sell Orthofix Medical stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Orthofix Medical stock. View analyst ratings for Orthofix Medical or view top-rated stocks. What is Orthofix Medical's stock price forecast for 2022? 1 Wall Street research analysts have issued 1 year target prices for Orthofix Medical's stock. Their OFIX stock forecasts range from $45.00 to $45.00. On average, they anticipate Orthofix Medical's stock price to reach $45.00 in the next year. This suggests a possible upside of 91.1% from the stock's current price. View analysts' price targets for Orthofix Medical or view top-rated stocks among Wall Street analysts. How has Orthofix Medical's stock price performed in 2022? Orthofix Medical's stock was trading at $31.09 at the beginning of the year. Since then, OFIX shares have decreased by 24.3% and is now trading at $23.55. View the best growth stocks for 2022 here. When is Orthofix Medical's next earnings date? Orthofix Medical is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022. View our earnings forecast for Orthofix Medical. How were Orthofix Medical's earnings last quarter? Orthofix Medical Inc. (NASDAQ:OFIX) released its earnings results on Friday, May, 6th. The medical device company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.18 by $0.28. The medical device company earned $106.42 million during the quarter, compared to the consensus estimate of $104.70 million. Orthofix Medical had a positive trailing twelve-month return on equity of 3.34% and a negative net margin of 7.96%. View Orthofix Medical's earnings history. What guidance has Orthofix Medical issued on next quarter's earnings? Orthofix Medical issued an update on its FY 2022 earnings guidance on Monday, June, 6th. The company provided earnings per share (EPS) guidance of $0.58-$0.73 for the period, compared to the consensus earnings per share estimate of $0.66. The company issued revenue guidance of $475.00 million-$490.00 million, compared to the consensus revenue estimate of $481.93 million. Who are Orthofix Medical's key executives? Orthofix Medical's management team includes the following people: Mr. Jon C. Serbousek, Pres, CEO & Director (Age 61, Pay $1.61M)Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 56, Pay $782.49k)Ms. Kimberley A. Elting, Chief Legal & Devel. Officer and Pres of the Global Orthopedics (Age 57, Pay $781.15k) (LinkedIn Profile)Mr. Kevin J. Kenny, Pres of Global Spine Bus. (Age 57, Pay $778.96k)Mr. Roberto Donadello, Sr. VP of Global OperationsDr. James T. Ryaby B.A., Chemistry, Ph.D., Chief Scientific Officer (Age 63)Mr. Dan E. Yarbrough, VP of Investor RelationsMs. Jill Mason, Chief Ethics & Compliance OfficerMs. Suzanne Armstrong, VP of HRMr. Ehab M. Esmail, Sr. VP of Quality, Regulatory & Clinical Affairs (Age 50) What is Brad Mason's approval rating as Orthofix Medical's CEO? 32 employees have rated Orthofix Medical CEO Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among Orthofix Medical's employees. Who are some of Orthofix Medical's key competitors? Some companies that are related to Orthofix Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), Baxter International (BAX), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Hologic (HOLX), Insulet (PODD) and Teleflex (TFX). View all of OFIX's competitors. What other stocks do shareholders of Orthofix Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR). What is Orthofix Medical's stock symbol? Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX." Who are Orthofix Medical's major shareholders? Orthofix Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (17.25%), Vanguard Group Inc. (10.80%), Paradice Investment Management LLC (5.06%), State Street Corp (3.98%), Polar Asset Management Partners Inc. (3.70%) and Dimensional Fund Advisors LP (3.37%). Company insiders that own Orthofix Medical stock include Brad Mason, Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Michael E Paolucci, Rice Doug and Ronald A Matricaria. View institutional ownership trends for Orthofix Medical. Which major investors are selling Orthofix Medical stock? OFIX stock was sold by a variety of institutional investors in the last quarter, including Polar Asset Management Partners Inc., Arrowstreet Capital Limited Partnership, State Street Corp, State of New Jersey Common Pension Fund D, Royce & Associates LP, Gabelli Funds LLC, Gabelli Funds LLC, and Renaissance Technologies LLC. View insider buying and selling activity for Orthofix Medical or view top insider-selling stocks. Which major investors are buying Orthofix Medical stock? OFIX stock was bought by a variety of institutional investors in the last quarter, including Endurant Capital Management LP, Heartland Advisors Inc., Dimensional Fund Advisors LP, Victory Capital Management Inc., Paradigm Capital Management Inc. NY, First Eagle Investment Management LLC, BlackRock Inc., and Engineers Gate Manager LP. Company insiders that have bought Orthofix Medical stock in the last two years include Catherine M Burzik, Jon Carl Serbousek, Kimberley A Elting, Michael E Paolucci, and Rice Doug. View insider buying and selling activity for Orthofix Medical or or view top insider-buying stocks. How do I buy shares of Orthofix Medical? Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Orthofix Medical's stock price today? One share of OFIX stock can currently be purchased for approximately $23.55. How much money does Orthofix Medical make? Orthofix Medical (NASDAQ:OFIX) has a market capitalization of $468.93 million and generates $464.48 million in revenue each year. The medical device company earns $-38.38 million in net income (profit) each year or ($1.860010) on an earnings per share basis. How many employees does Orthofix Medical have? Orthofix Medical employs 1,087 workers across the globe. When was Orthofix Medical founded? Orthofix Medical was founded in 1980. How can I contact Orthofix Medical? Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The official website for Orthofix Medical is www.orthofix.com. The medical device company can be reached via phone at (214) 937-2000, via email at [email protected], or via fax at 599 9 461 6978. This page (NASDAQ:OFIX) was last updated on 6/29/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here